GT Biopharma Inc. Common Stock GTBP

$11.63 +35.08% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-09-15 View →
8-K 8-K 2026-09-03 View →
8-K 8-K 2026-08-14 View →
10-Q 10-Q 2026-08-14 View →
DEF 14A DEF 14A 2026-07-02 View →
8-K 8-K 2026-06-12 View →
8-K 8-K 2026-05-22 View →
10-Q 10-Q 2026-05-15 View →
S-1 S-1 2026-04-30 View →
8-K 8-K 2026-04-07 View →
10-K 10-K 2026-03-02 View →
8-K 8-K 2026-03-02 View →
S-1 S-1 2026-01-21 View →
8-K 8-K 2025-11-26 View →
10-Q 10-Q 2025-11-14 View →
8-K 8-K 2025-11-14 View →
S-1 S-1 2025-10-24 View →
8-K 8-K 2025-09-26 View →
8-K 8-K 2025-09-23 View →
4 Insider transaction 2025-09-08 View →
4 Insider transaction 2025-09-08 View →
4 Insider transaction 2025-09-08 View →
4 Insider transaction 2025-09-08 View →
4 Insider transaction 2025-09-08 View →
8-K 8-K 2025-08-29 View →
10-Q 10-Q 2025-08-14 View →
8-K 8-K 2025-07-24 View →
S-1 S-1 2025-06-11 View →
DEF 14A DEF 14A 2025-06-11 View →
8-K 8-K 2025-06-11 View →
8-K 8-K 2025-05-27 View →
10-Q 10-Q 2025-05-15 View →
8-K 8-K 2025-05-13 View →
8-K 8-K 2025-05-13 View →
8-K 8-K 2025-05-05 View →
8-K Current report (material event) 2025-04-04 View →
S-3 Shelf registration 2025-03-06 View →
8-K Current report (material event) 2025-02-26 View →
10-K Annual report 2025-02-21 View →
8-K Current report (material event) 2025-01-27 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$11.63
Market Cap
$15.54 million
52-Week Range
$4.91 – $44.50
Average Volume
63K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.